Insider Transactions in Q1 2021 at Insmed Inc (INSM)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 16
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-7.71%
|
$1,800,000
$36.5 P/Share
|
|
Mar 16
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.88%
|
$150,000
$3.4 P/Share
|
|
Mar 11
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
23,717
-44.34%
|
$948,680
$40.0 P/Share
|
|
Mar 11
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,717
+30.72%
|
$711,510
$30.86 P/Share
|
|
Mar 10
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
500
-1.65%
|
$20,000
$40.0 P/Share
|
|
Mar 10
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+1.62%
|
$15,000
$30.86 P/Share
|
|
Mar 09
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
44,912
-33.36%
|
$1,796,480
$40.38 P/Share
|
|
Mar 09
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
44,912
+24.99%
|
$988,064
$22.84 P/Share
|
|
Mar 08
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,479
-5.43%
|
$94,202
$38.92 P/Share
|
|
Mar 08
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,709
+9.35%
|
$94,180
$20.49 P/Share
|
|
Mar 04
2021
|
Steinar J Engelsen |
BUY
Open market or private purchase
|
Direct |
2,710
+0.9%
|
$97,560
$36.9 P/Share
|
|
Feb 09
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
15,150
-9.72%
|
$681,750
$45.0 P/Share
|
|
Feb 09
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,150
+8.86%
|
$151,500
$10.85 P/Share
|
|
Feb 08
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
6,400
-4.35%
|
$275,200
$43.95 P/Share
|
|
Feb 08
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,400
+4.17%
|
$64,000
$10.85 P/Share
|
|
Jan 26
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,600
-1.81%
|
$114,400
$44.04 P/Share
|
|
Jan 26
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,600
+1.78%
|
$26,000
$10.85 P/Share
|
|
Jan 25
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
21,000
-6.86%
|
$903,000
$43.4 P/Share
|
|
Jan 25
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,000
+6.36%
|
$210,000
$10.85 P/Share
|
|
Jan 21
2021
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
1,031
+50.0%
|
-
|
|
Jan 21
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,031
-0.22%
|
-
|
|
Jan 21
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
20,000
-6.63%
|
$820,000
$41.51 P/Share
|
|
Jan 21
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+6.22%
|
$200,000
$10.85 P/Share
|
|
Jan 20
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
10,000
-6.63%
|
$390,000
$39.87 P/Share
|
|
Jan 20
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+6.22%
|
$100,000
$10.85 P/Share
|
|
Jan 12
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
2,541
-1.09%
|
-
|
|
Jan 07
2021
|
John Soriano Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,509
+15.61%
|
-
|
|
Jan 07
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,346
+15.22%
|
-
|
|
Jan 07
2021
|
Christine A Pellizzari Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,183
+6.13%
|
-
|
|
Jan 07
2021
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,039
+10.93%
|
-
|
|
Jan 07
2021
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,019
+10.06%
|
-
|
|
Jan 07
2021
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,183
+50.0%
|
-
|
|
Jan 07
2021
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,019
+34.85%
|
-
|
|
Jan 04
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-2.64%
|
$30,030
$33.42 P/Share
|
|
Jan 04
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-0.49%
|
$21,450
$33.42 P/Share
|
|
Jan 04
2021
|
William Lewis Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,963
-1.85%
|
$97,779
$33.42 P/Share
|
|
Jan 04
2021
|
Roger Adsett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-1.38%
|
$40,359
$33.42 P/Share
|
|
Jan 03
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
949
-2.68%
|
$31,317
$33.29 P/Share
|
|
Jan 03
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,814
-1.35%
|
$59,862
$33.29 P/Share
|
|
Jan 03
2021
|
John Soriano Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
949
-3.76%
|
$31,317
$33.29 P/Share
|
|
Jan 03
2021
|
William Lewis Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,255
-2.58%
|
$140,415
$33.29 P/Share
|
|
Jan 03
2021
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
949
-9.02%
|
$31,317
$33.29 P/Share
|
|
Jan 03
2021
|
Roger Adsett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,275
-2.5%
|
$75,075
$33.29 P/Share
|